Linneo Health and Phytocontrol Group sign exclusive medicinal cannabis clinical analysis collaboration agreement
Linneo Health and Phytocontrol Group sign exclusive medicinal cannabis clinical analysis collaboration agreement Agreement gives…
Linneo Health and Phytocontrol Group sign exclusive medicinal cannabis clinical analysis collaboration agreement Agreement gives…
QuantuMDx receives CDTA approval for sale of Q-POC™ SARS-CoV-2, Flu A/B & RSV Assay NEWCASTLE…
Balixafortide shown to have synergistic or additive effect with conventional or targeted therapies across all…
TOKYO and CAMBRIDGE, United Kingdom, Dec. 13, 2022 (GLOBE NEWSWIRE) — Sosei Group Corporation (“the…
6 out of 7 eligible patients with relapsed/refractory Non-Hodgkin Lymphoma (rrNHL) responded to treatment (ORR…
Internet City, Dubai–(Newsfile Corp. – December 13, 2022) – LBank Exchange, a global digital asset…
Internet City, Dubai–(Newsfile Corp. – December 13, 2022) – LBank Exchange, a global digital asset…
Internet City, Dubai–(Newsfile Corp. – December 13, 2022) – LBank Exchange, a global digital asset…
Highlights Infinity Stone has completed two of three holes on the Buda Lithium Winter Drill…
Mountain View, Calif., Dubai, UAE and Mumbai, India, Dec 13, 2022 – (ACN Newswire) –…
Kantata’s professional services automation solution to assist Deloitte CE in daily operations IRVINE, Calif. &…
Data-driven future of insurance will only become reality if insurers can convince customers on data…
Avery Restaurant Consulting now offers new menu consulting and staff training for restaurants in Boston….
SINGAPORE, Dec 13, 2022 – (ACN Newswire) – Rokko Holdings Ltd (“Rokko”) has marked its…
HONG KONG, Dec 13, 2022 – (ACN Newswire) – OrbusNeich Medical Group Holdings Limited (“OrbusNeich”…
KUALA LUMPUR, Malaysia–(BUSINESS WIRE)–PETRONAS has recently inked a Memorandum of Understanding (MoU) with global technology…
ST. LOUIS–(BUSINESS WIRE)–Enterprise Financial Services Corp (Nasdaq: EFSC) today announced the appointment of Lyne B….
HIGHLIGHTS Files its first IND application for a CAR-T cell therapy targeting a solid cancer….
–NGM936, a ILT3 x CD3 bispecific T cell engager product candidate, potently induced T cell…
Updated Results from CHARIOT Phase 2 trial presented at the 2022 ASH Annual Meeting indicate…